TargImmune Therapeutics is focused on drug development using novel targeted onco-immunotherapies.
TargImmune Therapeutics has raised €16M across 1 funding round, most recently a round in Jul 2021. Based in Basel, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-20 | Other | €16M |
| — |
| View deal → |
